Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from CSPC Pharmaceutical Group ( (HK:1093) ) is now available.
CSPC Pharmaceutical Group Limited has announced the composition of its Board of Directors, detailing the roles and functions of each member. This announcement is crucial for stakeholders as it outlines the leadership structure and governance, which can impact the company’s strategic direction and operational effectiveness.
The most recent analyst rating on (HK:1093) stock is a Hold with a HK$8.50 price target. To see the full list of analyst forecasts on CSPC Pharmaceutical Group stock, see the HK:1093 Stock Forecast page.
More about CSPC Pharmaceutical Group
CSPC Pharmaceutical Group Limited is a Hong Kong-based company operating in the pharmaceutical industry. It focuses on the development, manufacturing, and sale of a wide range of pharmaceutical products.
Average Trading Volume: 165,026,203
Technical Sentiment Signal: Buy
Current Market Cap: HK$88.46B
For an in-depth examination of 1093 stock, go to TipRanks’ Overview page.